CUV clinuvel pharmaceuticals limited

Ann: Appendix 4E and Annual Report 2022, page-9

  1. 233 Posts.
    lightbulb Created with Sketch. 27
    I think by the reaction of the market since the earnings report, the market has viewed the NPAT decrease as a nothing burger. There is positive sentiment on CUV at the moment, especially on the charts now too. Main thing is to break the 200 day moving average and start developing new uptrend. If it happens, this is one stock I'm happy to average up and buy the dips against a falling market. In saying that, a bit overbought now and expect pullback from hitting 200 day moving avg.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$10.09
Change
-0.070(0.69%)
Mkt cap ! $505.7M
Open High Low Value Volume
$10.18 $10.26 $9.96 $484.7K 47.82K

Buyers (Bids)

No. Vol. Price($)
1 1627 $10.09
 

Sellers (Offers)

Price($) Vol. No.
$10.25 2834 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.